ProPhase Labs, Inc. (PRPH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 5.0600 |
| Open | 5.0600 |
| Bid | 4.8100 x 100 |
| Ask | 5.1100 x 100 |
| Day's range | 4.9000 - 5.1150 |
| 52-week range | 4.0500 - 9.9400 |
| Volume | |
| Avg. volume | 51,467 |
| Market cap | 89.324M |
| Beta (5Y monthly) | -0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 24 May 2022 |
| 1y target est | N/A |
- Zacks
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Insider Monkey
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript March 15, 2024 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.27. PRPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Noella Alexander-Young: Hello, and good […]
- Simply Wall St.
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
Key Insights The projected fair value for ProPhase Labs is US$3.46 based on Dividend Discount Model ProPhase Labs is...
© 2024 Yahoo. All rights reserved.